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Introduction 
It is important to improve our understanding of how 
the serotonin (5-HT) system is controlled because it is 
involved in the etiology of common psychiatric dis-
orders such as depression (Blier and de Montigny, 
1998), obsessive compulsive disorder (Baumgar-
ten and Grozdanovic, 1998), schizophrenia (Agha-
janian and Marek, 2000) and alcoholism Heinz et al., 
2001; Hill et al., 1999). It is likely that certain combi-
nations of common genetic variants confer different 
risk profiles and treatment prognoses for their carri-
ers than do other combinations and that such gene–
gene interactions may be more important in common 
disorders than are main effects of any single gene 
(Moore, 2003). A more complete understanding of 
the relations among genetically varying system com-
ponents in the regulation of 5-HT function that in-
cludes epistasis has the potential to improve psychi-
atric treatment by providing a theoretical framework 
for genetically individualized therapy based on phar-
macogenetic profiling (Lesch, 2002). 
The terms physiological or mechanistic epistasis 
describe a situation wherein the effect on a pheno-
type of a particular allele at a locus depends on the 
allelic state of one or more other loci (Brodie, 2000). 
Such epistatic interactions are likely in traits with 
complex genetic architectures and blur the distinc-
tion between ‘‘major’’ and ‘‘minor’’ genetic effects 
because the effect of a given allele on a phenotype 
is not a property of that allele, but is context depen-
dent (Templeton, 2000). Physiological epistasis does 
not appear to be rare, and in fact, in the genetic archi-
tecture of common human diseases, epistasis may be 
ubiquitous (Moore, 2003). Therefore, it is reasonable 
to seek evidence for epistasis in physiological systems 
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Abstract 
Epistatic interactions among regulatory components of the serotonin (5-HT) neurotransmitter system may 
be an important aspect of 5-HT function. Because 5-HT dysregulation is associated with several common 
psychiatric disorders, the potential for epistasis among genetic variants in the 5-HT transporter (SERT), 
5-HT1B terminal autoreceptor and the 5- HT1A somatodendritic autoreceptor should be examined. In this 
study, output from a dynamic minimal model of 5-HT function was compared to empirical results in the 
literature. Parameters representing extracellular 5-HT clearance rates (SERT), 5-HT release levels (5-HT1B) 
and inhibitory thresholds (the amount of extracellular 5-HT above which cell firing is inhibited, an indi-
cation of 5-HT1A autoreceptor sensitivity) were varied to simulate genetic deletion (i.e., knockout) of each 
component singly, and in combination. Simulated knockout effects on extracellular 5-HT level and pre-
synaptic neural firing rates were in the same direction and of similar relative magnitude as studies in the 
literature. Epistasis among presynaptic components appears to be important in the 5-HT system’s regula-
tion of extracellular 5-HT levels, but not of firing rates. 
Keywords: Dynamic systems, epistasis, knockout, serotonin, SERT, 5-HT1A, 5-HT1B.
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where components interact; and the 5-HT system is a 
good candidate system in which to seek evidence of 
epistasis because it is comprised of multiple, interac-
tive components that vary genetically and because 5-
HT dysfunction is associated with risk for common 
psychiatric disorders (Veenstra-VanderWeele et al., 
2000). 
Experimental strategies that use lines of mice with 
genetic deletions (i.e., knockouts) have been em-
ployed to investigate the contribution of serotonin 
transporters (Gobbi et al., 2001; Mannoury la Cour 
et al., 2001), 5-HT1A somatodendritic (He et al., 2001; 
Knobelman et al., 2001a, b; Parsons et al., 2001; Richer 
et al., 2002) and 5-HT1B terminal autoreceptors (de 
Groote et al., 2002; Evrard et al., 1999; Knobelman et 
al., 2001a, b; Malagie et al., 2002) to the regulation of 
5-HT function. Studies using in vivo microdialysis (de 
Groote et al., 2002; He et al., 2001; Knobelman et al., 
2001a, b; Malagie et al., 2002; Parsons et al., 2001) and 
single unit cell recording Evrard et al., 1999; Gobbi et 
al., 2001; Mannoury la Cour et al., 2001; Richer et al., 
2002) have provided valuable data on extracellular 5-
HT concentration and cell firing rates, respectively. 
Although there is evidence that the effects of each 
component may not be the same in different brain re-
gions (Knobelman et al., 2001a, b; Malagie et al., 2002), 
it is clear that the 5-HT transporter (SERT) and the au-
toreceptors contribute to 5-HT regulation. Studying 
knockout mice has provided substantial suggestive 
evidence for epistatic effects on traits influenced by 5-
HT function when components are jointly examined 
by genetic deletion and/ or pharmacological manipu-
lation (de Groote et al., 2002; Evrard et al., 1999; Gobbi 
et al., 2001; He et al., 2001; Knobelman et al., 2001a, b; 
Malagie et al., 2002; Murphy et al., 2001; Parsons et al., 
2001). 
A negative feedback framework is generally ac-
cepted to underlie the regulation of the 5-HT system 
(Aghajanian and Sanders-Bush, 2002); however, a 
systematic quantitative examination of such a model 
has not been carried out with computer simulation. 
In this study, I present a quantitative model of nega-
tive feedback regulation of presynaptic 5-HT function 
and compare simulation-generated results with ex-
tant empirical results from the literature. This model 
is not intended to simulate the function of single neu-
ron; rather, it is a ‘‘top down’’ look at the regulation 
of the central 5-HT system. In a sense, this model may 
be considered a caricature of how genetically varying 
components in the 5-HT system may influence indi-
ces of 5-HT function. As with all caricatures, it is in-
tended to capture the essence of the subject in broad 
strokes, not to replicate the subject in minute detail. 
Variables in the simulation modeled genetic deletion 
of SERT, somatodendritic 5-HT1A and terminal 5-HT1B 
autoreceptors. The simulation incorporates dynamic 
rules to adjust somatodendritic autoreceptor sensitiv-
ity and terminal autoreceptor mediated 5-HT release 
amounts. The purpose of this study, was to examine 
the general hypothesis that presynaptic 5-HT function 
is influenced by epistatic interactions among SERT 
and the somatodendritic 5-HT1A and terminal 5-HT1B 
autoreceptors. Comparing simulation results with mi-
crodialysis and single- unit recording results from the 
empirical literature should determine whether this 
interactive, dynamic, three-component model of pre-
synaptic 5-HT control is sufficient to capture the dy-
namics of 5-HT regulation. 
Method
Software 
Because system dynamics models are well suited to 
analyze biological control systems (Gallaher, 1996) 
this model was implemented using Berkeley Ma-
donna 8.0.1 (Zahnley, 2000); a commercially available 
simulation tool. The simulation was conducted by 
numerically solving differential equations. The code 
used to generate data is included in the Appendix 1. 
The Model 
Perhaps the most intuitive way to describe the model 
is by referring to the component parts and behavior of 
a single neuron. However, it should be kept in mind 
that for the present model the level of analysis is con-
ceptualized as the central 5-HT system consisting of 
tens of thousands of neurons originating in the raphe 
nucleus and projecting to most brain areas (Baumgar-
ten and Gothert, 1999). 
Vesicular releases triggered by action potentials in-
troduce serotonin into the extracellular compartment 
(see Figure 1). Aspects of serotonin release are de-
termined by terminal (1B) and somatodendritic (1A) 
autoreceptors. Somatodendritic autoreceptors de-
termine whether the system releases any serotonin 
(i.e., whether the system ‘‘fires’’) based on a compari-
son of the level of extracellular serotonin to an inhib-
itory threshold. If the level of extracellular serotonin 
exceeds the inhibitory threshold the somatodendritic 
autoreceptors inhibit system firing (i.e., no serotonin 
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is released). Conversely, if the level of extracellular 
serotonin is below the inhibitory threshold the so-
matodendritic autoreceptors permit firing. Based on 
this firing decision the threshold is adjusted to either 
increase or decrease receptor sensitivity such that if 
the system has just fired, the threshold is decreased 
to make it less likely that the system will fire at the 
next time step; whereas if the system did not fire, the 
inhibitory threshold is increased to make firing more 
likely at the next time step. Genetic variation at the 
5-HT1A autoreceptor is assumed to affect the rate at 
which changes in sensitivity occur. 
When the system fires, the amount of serotonin to 
be released into the extracellular compartment for 
that particular time step is determined by the termi-
nal (1B) autoreceptor. For normal functioning, it is as-
sumed that the terminal autoreceptor adjusts the re-
lease amount according to the level of serotonin in 
the extracellular compartment. That is, when extra-
cellular serotonin levels are high, less serotonin is re-
leased, and when levels are low, more serotonin is re-
leased. Genetic variation at the 5-HT1B autoreceptor is 
assumed to eliminate such responsiveness to the level 
of serotonin in the extracellular compartment so that 
level of serotonin released remains constant. 
Serotonin flows out of the extracellular compart-
ment by transporter mediated reuptake and by diffu-
sion. Reuptake and diffusion are modeled to remove 
a proportion of the serotonin in the extracellular com-
partment at each time step. For normal functioning 
it is assumed that reuptake removes 90% of the sero-
tonin in the extracellular compartment and that diffu-
sion removes the remaining 10%. Genetic variation in 
serotonin transporter (SERT) function is assumed to 
reduce the reuptake percentage. The rate of diffusion 
is assumed to be constant. 
Extracellular 5-HT 
Serotonin enters the extracellular compartment by 
way of vesicular release and is removed actively by 
reuptake and passively by diffusion. The dynamics of 
extracellular 5-HT (Y) is characterized by 
dY/dt  = ρ – (υY + δY)                             (1)
where Y denotes the amount of 5-HT in the extracellu-
lar compartment, ρ represents the rate at which 5-HT 
added to the extracellular compartment (e.g., via vesic-
ular release), and υ represents the rate at which 5-HT is 
removed from the extracellular compartment via reup-
take, and where δ represents rate of diffusion. 
Somatodendritic Autoreceptor 
When the level of 5-HT in the extracellular compart-
ment exceeds an inhibitory threshold somatoden-
dritic autoreceptors (i.e., 5-HT1A) inhibit neural firing. 
In this simulation, it is assumed that 5-HT1A autore-
ceptors dynamically adjust their inhibitory thresh-
olds such that 5-HT neurons maintain a characteris-
tic, regular firing rate across a range of extracellular 
5-HT levels. The dynamic inhibitory threshold in this 
negative feedback loop is characterized by 
dT/d = T + A                                    (2)
where T denotes the inhibitory threshold (in 5-HT 
units) and A represents a conditional adjustment 
factor, based on whether the system ‘‘fired’’ (i.e., re-
leased 5-HT). The equation for the adjustment factor 
is characterized by 
A(t) =
 { κ    if ρ = 0,                            (3)                                            λ    if ρ > 0
where κ > 0, that is, κ increases the inhibitory thresh-
old, making it more likely that the system will fire at 
the next time step; and λ < 0, that is, λ decreases the 
inhibitory threshold, making it less likely that the sys-
tem will fire at the next time step. 
Figure 1. Dynamic model of presynaptic 5-HT system reg-
ulation: Y denotes extracellular 5-HT level, ρ denotes the 
release rate, υ denotes the reuptake rate, δ denotes the dif-
fusion rate and T denotes the inhibitory threshold. See text 
for a detailed explanation of the model and for equations. 
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We defined the inhibitory threshold (T) as the 
amount of extracellular 5-HT above which presyn-
aptic 5-HT neural firing is inhibited. That is, T repre-
sents the sensitivity of somatodendritic autoreceptors. 
Initial T values are set below the level of the aver-
age release value because it was reasoned that firing 
should be inhibited if the amount of neurotransmit-
ter remaining in the extracellular space was equal to 
or greater than the average release amount. This as-
sumes that for proper neurotransmission a substan-
tial amount of neurotransmitter must be cleared from 
the extracellular space before another firing event is 
permitted to occur. 
Terminal Autoreceptor 
Terminal autoreceptors (i.e., 5-HT1B) influence the 
amount of 5-HT released per release event. In this 
model the amount of 5-HT to be released is a func-
tion of a constant baseline release value (B) that is 
corrected with respect to the amount of 5-HT in the 
extracellular compartment (i.e., is inversely propor-
tional to). Therefore, terminal autoreceptor regulation 
of release is characterized by 
ρ = [ (     B    ) Ä C ]                            (4)                                        Y + 1
where B represents a constant release value (50) and 
Y denotes amount of 5-HT in the extracellular com-
partment. To avoid having a zero in the denominator, 
Y + 1 is used. To achieve reasonable release values a 
correction factor is used, where C is a constant (100). 
Outcome Measures 
Level of extracellular 5-HT was an outcome variable 
of primary interest. For each simulation run the ini-
tial starting level of extracellular 5-HT (i.e., Y(0)) was 
set at 50. Parameter plots that varied the initial level 
of 5-HT from 0 to 500 had no effect on outcome vari-
ables. Parameter plots that varied the initial inhibi-
tory threshold (T) from 0 to 500 had no effect on EX-
SER, but increased SERFIRE Rate (ratio of times fired 
to time steps) linearly from 0.49 to 0.59 (data not 
shown). The initial value for T (50) was chosen so 
that at baseline the system maintained a regular fir-
ing rate (around 0.50) and with tight regular oscilla-
tions around the inhibitory threshold, and because 
it was assumed that the initial inhibitory threshold 
should be below the average release value so that if 
most of the 5- HT from a single release remained in 
the synapse the system would be inhibited firing at 
the next time step. The exact value of T(initial) = 50 was 
arbitrary. 
The other outcome variable of primary interest was 
‘‘Firing Rate’’ defined as the number of times that the 
system fired (i.e., released 5-HT) divided by the num-
ber of time steps. For each model condition, extracel-
lular 5-HT Level and firing rate were recorded after 
50,000 time steps. Because randomness was not built 
into the model, one run for each condition was suffi-
cient to produce outcomes that may be considered the 
true values of those indices (i.e., additional runs un-
der the same conditions produced identical values). 
Model Verification 
To verify that the model is doing what is expected, 
the following approach was taken. First, parameter 
plots were generated for each outcome variable across 
ranges of an independent variable (e.g., reuptake rate) 
and these were inspected for conceptual coherence. 
Next, the baseline outcomes for the model were es-
tablished by performing a run of 50,000 time steps. 
Then for each of the parameters of interest (SERT [S], 
5-HT1A [A]; 5-HT1B [B]) we set each to simulate a loss 
of function due to genetic deletion (i.e., knockout, see 
Table I). Results were compared to those in the em-
pirical literature with respect to direction and magni-
tude of effect. 
Data Analysis and Statistics 
The effects of manipulating reuptake rate (i.e., SERT 
KO), 5-HT1A somatodendritic autoreceptor function 
(i.e., 5-HT1A KO) and 5-HT1B terminal autoreceptor 
function (i.e., 5-HT1B KO) on simulated extracellular 
5-HT level and firing rate were examined. The effect 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table I. Model parameters. 
   Baseline     KO  
Knockout  Genotype  Variable  value  value 
SERT  S–/A+/B+  Reuptake  0.90  0.00  
  rate (υ) 
5-HT1A  S+/A–/B+  Threshold  
  adjustment (λ)  –5  –1  
5-HT1B  S+/A+/B–  Release (ρ)  [(B/Y+1) Ä C] 100 
B represents a release constant, set at 50, and C represents an 
adjustment factor set at 100. Y represents the amount of 5-HT 
detected in the extracellular compartment. 
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of each simulated condition was examined indepen-
dently, as well as in logical combinations with the 
other conditions (i.e., double and triple knockouts). 
For statistical analyses, raw data were used. The 
Mann–Whitney test used to examine single gene ef-
fects. Although the outcome measures are accurate 
population parameters, assessing the effect of knock-
ing out a single gene in this study required the com-
parison of two groups, each with N = 4. Rank order 
methods seemed preferable to parametric methods 
for such comparisons. For the multiple knockout con-
ditions, visual inspection of histograms was used to 
assess epistatic interactions. Interactions were not for-
mally tested because of concerns regarding the power 
of non-parametric statistical tests to detect interac-
tions when the total N = 8. However, because the out-
come values can be considered population param-
eters (i.e., no uncertainty) it seemed reasonable to 
assess interaction through visual inspection of the 
output in line figures. Departures from parallel indi-
cate the presence of interaction. For the Figures, the 
baseline extracellular 5-HT level (Exser) and firing 
rate (Serfire) were set to 100% and knockout values 
are shown relative to baseline. 
Results
Parameter Plots 
Parameter plots were generated to assess change in 
level of extracellular 5-HT (Exser) and system firing 
rate (Serfire) across the range of a single parameter 
(see Figure 2). 
Varying the reuptake rate had no substantial effect 
on Serfire, but did affect Exser (see Figure 2a). Reduc-
ing reuptake is known to increase extracellular levels 
of 5-HT and temporarily reduces firing rate. Down 
regulation or desensitization of somatodendritic au-
toreceptors (5-HT1A) allows neural firing at higher 
levels of extracellular 5-HT and this dynamic model 
captures this adaptation as shown by the high levels 
of Exser at low uptake rates and firing rates that are 
little changed relative to baseline. 
The threshold adjustment λ represents antagonism 
of the 5-HT1A autoreceptor that inhibits firing when 
activated, therefore, blocking an inhibitory function 
would raise the inhibitory threshold (i.e., allowing the 
system to fire at elevated levels of extracellular 5-HT). 
Reducing λ permits system firing at higher Exser lev-
els thereby resulting in higher Exser levels and higher 
rates of firing [see Figure 2(b)]. Recall that κ raises 
the inhibitory threshold, while λ lowers it. When κ 
> λ, the inhibitory threshold rises faster than it falls, 
which results in higher levels of the inhibitory thresh-
old overall. 
Varying the release constant (B) has no effect on 
Serfire, but is positively associated with Exser (see 
Figure 2c). It is logical that higher rates of release will 
increase Exser levels when all other variables remain 
constant. 
The behavior of the model, as shown in these pa-
rameter plots, is consistent with expectations, thereby 
achieving a basic level of model verification (Rykiel, 
1996). 
Baseline Levels 
Running the model with the baseline values given 
in Table I produced an extracellular 5-HT level of 
Figure 2. Parameter plots generated by varying one parame-
ter while holding others at baseline level. Each graph shows 
curves for extracellular 5-HT level (Exser, black square) and 
presynaptic system firing rate (Serfire, white square). Baseline 
level was set to 100%. Parameter plots are shown for (a) reup-
take rate simulating variation in 5-HT transporter function, (b) 
threshold adjustment simulating variation in 5-HT1A somato-
dendritic autoreceptor function, (c) release constant simulat-
ing variation in 5-HT1B terminal autoreceptor function.  
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49.38 units, and a firing rate of 0.50 (i.e., 25,000 fir-
ings/50,000 time steps). The raw values were then set 
to 100% to facilitate visual comparisons with the sim-
ulated knockout conditions. 
Knockouts 
To examine the effect of genetic deletion of compo-
nents in this minimal model of presynaptic 5- HT 
function, baseline values were systematically re-
placed with the knockout values shown in Table I 
to simulate seven knockout conditions (three single, 
three double, and one triple knockout). For the analy-
sis of single gene effects, the Mann–Whitney test was 
used (Table II). 
Single Knockouts 
For Exser, the main effect of SERT knockout was sig-
nificant, U = 0.00, p = .02. Mean Exser rank for the 
SERT knockout conditions (S– = 6.5) was higher 
than mean Exser for the functional SERT conditions 
(S+ = 2.5). For Serfire, the main effect of SERT knock-
out was not significant, U = 4.0, p = .25. Mean Serfire 
rank for the SERT knockout conditions was (S– = 3.5) 
and for the functional SERT conditions it was (S+ = 
5.5). Consistent with the parameter plot results, re-
ducing reuptake rate (i.e., knockout out SERT func-
tion) increased levels of extracellular 5-HT and pro-
duced essentially no change in firing rates. Firing 
inhibition is initially observed in the SERT knock-
out condition (data not shown). However, because 
the inhibitory threshold dynamically responds to 
changes in 5-HT levels, the firing rates after 50,000 
time steps are not significantly reduced relative to 
non-knockout conditions. 
For Exser, the main effect of 5-HT1A knockout was 
not significant, U = 5.00, p = .39. Mean Exser rank 
for the 5-HT1A knockout conditions was (A– = 5.25) 
and for the functional 5-HT1A conditions it was (A+ = 
3.75). For Serfire, the main effect of 5-HT1A knockout 
was significant U = 0.00, p = .02. Mean Serfire rank 
for the 5- HT1A knockout conditions (A– = 6.5) was 
higher than mean Serfire rank for the functional 5-
HT1A conditions (A+ = 2.5). 
For Exser, the main effect of 5-HT1B knockout was 
not significant, U = 5.00, p = .34. Mean Exser rank 
for the 5-HT1B knockout conditions was (B– = 5.25) 
and for the functional 5-HT1B conditions it was (B+ = 
3.75). For Serfire, the main effect of 5-HT1B knockout 
was not significant U = 6.5, p = .66. Mean Serfire rank 
for the 5-HT1B knockout conditions was (B– = 4.13) 
and for the functional 5-HT1B conditions it was (B+ = 
4.88). 
Multiple Knockouts 
In order to identify potential gene–gene interactions 
on the level of extracellular 5-HT (Exser) the results 
of simulation runs are shown in Figure 3. Results for 
the wild type (+) and knockout (–) alleles for both the 
5-HT1A (A) and 5-HT1B (B) autoreceptors are shown in 
combination and grouped by SERT (S) genotype. The 
values shown are relative to the baseline (S+/A+/B+) 
condition, which is set to 100%. Little variation is seen 
across A and B genotypes in the S+ condition. How-
ever, in the S– condition, substantial increases in Exser 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table II. Effects of genetic deletion or pharmacological agents 
on 5-HT level and 5-HT cell firing rates in empirical literature. 
                                            5-HT     Firing  
Knockout    Genotype     Level       rate     Citation 
Single  S–/A+/B+  ↑↑  ↓/0  de Groote et al., (2002),  
    Evrard et al., (2002),  
    Gobbi et al., (2001),  
    Knobelman et al., (2001b),  
   Malagie et al., (2002) and  
    Mannoury la Cour et al., (2001) 
 S+/A–/B+  0/↑  ↑  He et al., (2001),  
    Knobelman et al., (2001),  
    Parsons et al., (2001) and  
    Richer et al., 2002 
S+/A+/B–  0  0/↓  de Groote et al., (2002),  
    Evrard et al., (1999),  
    Knobelman et al., (2001) 
Double  S–/A–/B+  ↑↑↑  ↑  Gobbi et al., (2001),  
    He et al., (2001),  
    Knobelman et al., (2001),  
    Knobelman et al., (2001),  
    Parsons et al., (2001) 
S–/A+/B–  ↑↑↑  ↓/0  de Groote et al., (2002),  
    Evrard et al., (1999),  
    Knobelman et al., (2001),  
    Knobelman et al., (2001),  
    Malagie et al., (2002) 
 S+/A–/B–  ?  ? None 
Triple  S–/A–/B–  ↑↑↑  ?  Knobelman et al., (2001) 
S– = SERT KO, A– = 5-HT1A KO, B– = 5-HT1B KO. Increases are in-
dicated by arrows: 100–200%=↑, 200–600%=↑↑, over 600% = ↑↑↑; De-
creases are indicated by ↓. No change is indicated by 0. No report in 
literature = ?. When no knockout data was available in the literature, 
data from pharmacological challenge studies was used (most often in 
double and triple knockout conditions). 
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are observed such that knocking out A and B aug-
ments the Exser increase seen in the S knockout, and 
the triple knockout produces the highest observed 
Exser levels. Different patterns of results between the 
S+ and S– groups suggest that epistatic interactions 
among SERT and the 1A and 1B autoreceptors influ-
ence extracellular 5-HT levels. 
In order to identify potential gene–gene interac-
tions on firing rate (Serfire) the results of simulation 
runs are shown in Figure 4. Results of the S and B 
knockout conditions are grouped by A genotype. The 
two lines are parallel which suggests that that SERT 
and the 1A and 1B autoreceptors do not interact to in-
fluence rates of 5-HT neural firing. 
Discussion
The main finding of the present study is that an over-
simplified, top down, dynamic model of 5- HT sys-
tem regulation reproduced important aspects of 5-
HT function, and that simulation results suggest that 
epistasis among system components may influence 
aspects of system function, specifically extracellular 
5-HT level. The simulation results were largely con-
sistent with recent empirical results from microdialy-
sis and electrophysiological studies in mice. Reducing 
clearance rates, which in the model simulates the re-
duction of SERT function by genetic deletion, raised 
extracellular 5-HT levels. Knocking out the 5-HT1A 
and/or 5-HT1B autoreceptors in the SERT knock-
out augmented the observed increase in extracellu-
lar 5-HT that resulted from reducing SERT mediated 
clearance rates alone. The highest levels of extracellu-
lar 5-HT were achieved in the triple knockout condi-
tion. Knocking out the function of the 5HT1A somato-
dendritic autoreceptor in the simulation produced 
higher system firing rates, but did not substantially 
affect levels of extracellular 5-HT. Knocking out the 
only function of the 5-HT1B terminal autoreceptor in 
the simulation did not affect extracellular 5-HT levels 
or firing rates. However, when the 5-HT1B terminal 
autoreceptor was knocked out in combination with 
other components the resulting patterns of extracellu-
lar 5- HT level suggested significant epistatic interac-
tion. These simulation results are consistent with the 
empirical literature on knockout mice. 
In wild-type mice, SSRI treatment raised extra-
cellular levels of 5-HT to 200–300% of baseline (de 
Groote et al., 2002; He et al. 2001; Malagie et al., 2002; 
Parsons et al., 2001); and extracellular 5-HT enhance-
ment is expected, but has not been reported in SERT 
knockout mice. The extracellular 5-HT enhancing ef-
fects of SSRI administration were augmented in 5-
HT1A and 5-HT1B knockout mice, relative to wild 
type, as well as in wild-type mice treated with a 5-
HT1A or 5-HT1B antagonist (de Groote et al., 2002; He 
et al., 2001; Knobelman et al., 2001a, b). These same 
patterns of results were observed in the present sim-
ulation study, if one assumes similarity, on a gross 
level, of SERT KO and SSRI treatment. Both reduce 
5-HT reuptake, although constitutive knockouts re-
sult in developmental effects that acute SSRI treat-
ment do not (Salichon et al., 2001). Another difference 
that can be seen between constituative knockouts and 
Figure 3. Simulated levels of extracellular 5-HT for condi-
tions defined by 5-HT transporter (S), 5-HT1B (B) and 5-HT1A 
(A) genotypes. The wild-type state is indicated by (+) and the 
knockout state is indicated by (–). Baseline (S+/B+/A+) is set 
to 100%. Differences in the pattern of B/A genotype effects 
across S genotype groups are evidence of epistatic interaction 
among components for extracellular 5-HT level.  
Figure 4. Simulated rates of presynaptic 5-HT firing for condi-
tions defined by 5-HT transporter (S), 5-HT1B (B) and 5-HT1A 
(A) genotypes. The wild-type state is indicated by (+) and the 
knockout state is indicated by (–). Baseline (A+/S+/B +) is set 
to 100%. Parallel lines across A genotype groups indicates that 
there is no epistatic interaction among components for firing 
rate. 
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acute SSRI treatment in the firing rate of 5-HT neu-
rons. Complete firing inhibition can be achieved with 
SSRI treatment (Evrard et al., 1999, 2002), whereas ge-
netic deletion of SERT produces 5-HT firing rates that 
are either no different than wild type (Mannoury la 
Cour et al., 2001), or somewhat reduced (Gobbi et al., 
2001). Desensitization of somatodendritic 5-HT1A au-
toreceptors in SERT knockouts permits firing of 5-HT 
neurons (Gobbi et al., 2001), and it is thought that this 
dynamic change in autoreceptor sensitivity may un-
derlie the therapeutic delay observed in SSRI treat-
ment for depression, though the exact mechanism is 
not completely characterized (Hensler, 2002). 
Simulation results showed a modest increase in 5-
HT level in the 5-HT1A KO condition (129% of base-
line value), in contrast to the results of several empir-
ical studies where extracellular 5-HT levels in 5-HT1A 
knockout mice are not different from that observed 
in wild-type mice (de Groote et al., 2002; Evrard et al., 
2002; He et al., 2001; Knobelman et al., 2001b; Richer et 
al., 2002), although a modest increase in extracellular 
5-HT was reported in one study Parsons et al., 2001). 
It may be that this discrepancy is a signal that there 
is some misspecification in the theoretical model un-
derlying the simulation (e.g., lack of a relevant adap-
tation mechanism or less than optimal parameter val-
ues) or to differences in extracellular 5-HT level that 
are below the threshold of detection of the microdial-
ysis techniques used. It is also possible that epistatic 
interactions among 5-HT1A mutant alleles and one or 
more unmeasured background alleles might mask the 
effect of the genetic deletion Palmer et al., 2003). 
There are some limitations of the simulation that 
should be considered. Expression or functional differ-
ences among different brain regions in terminal auto-
receptors (Fabre et al., 2000; Knobelman et al., 2001a, 
b; Malagie et al., 2002), somatodendritic autorecep-
tors (Fabre et al., 2000; Knobelman et al., 2001a, b; 
Mannoury la Cour et al., 2001), or transporters Mon-
tanez et al., 2002) were not considered in this simula-
tion. The model also did not address 5-HT synthesis, 
metabolism or post-synaptic effects. However, given 
that the simulation produced output with a high de-
gree of consistency with empirical observations, such 
shortfalls do not appear to detract from the potential 
usefulness of the model for understanding global as-
pects of 5-HT regulation. 
The relation of the time steps in the model to real 
time units is not immediately obvious. Microdialysis 
and single-unit recording measurements are usually 
performed on quite different time scales and not si-
multaneously in the same animal. In the simulation, 
the first few time steps (approximately 20 or 30) cap-
ture the firing inhibition mediated by the 5- HT1A au-
toreceptors; whereas the values reported in this study 
are those observed at time step 50,000 well after dy-
namic adjustments to the inhibitory threshold have 
taken place (i.e., equilibrium has been established). 
Run time parameters in the present model could be 
optimized to fit particular time scales, however, it 
seems that the real contribution of this model is to 
provide a flexible platform for thinking about and 
generating hypotheses about the relations among sys-
tem parameters and outcomes. 
Comparing the simulation results to empirical re-
sults from the literature identifies several instances 
where directional hypotheses can be made to fill in 
gaps in the empirical literature. We were unable to 
identify empirical data for comparison to the results 
for 5-HT firing rates in 5-HT1A and 5-HT1B double 
knockouts, but the simulation results suggest that the 
firing rates of 5-HT neurons would be elevated (167%) 
as would levels of extracellular 5-HT (169%) relative 
to wild type. In a triple KO mouse, results from the 
simulation predict that firing rates of 5-HT neurons 
would be elevated (167%) relative to wild type. In 
each of these cases, the simulation results can serve 
as directional hypotheses to be tested with microdial-
ysis or electrophysiology studies in mice. Such stud-
ies will further test the validity of the present model 
of presynaptic 5-HT regulation. Generation of test-
able hypotheses is an important aspect of simulation 
(Gallaher, 1996). This model of 5-HT function could 
also be used to simulate human genetic variation by 
using less extreme parameter values than were used 
here to simulation genetic deletion (Montanez et al., 
2003). The simulation could also be used to exam-
ine the effects of pharmacological agents that act at 
the three presynaptic 5-HT components examined in 
the model. In an extension to the model, we exam-
ined the effects of a common SERT promoter vari-
ant (5-HTTLPR) on 5-HT and dopaminergic function 
in the context of pharmacological treatment for alco-
holism (Stoltenberg, 2003). Other extensions of this 
model are being planned to address some of its cur-
rent shortcomings, including the addition of an early 
life stress variable, because of the important of early 
life stress in 5-HT function and in traits influenced by 
5-HT (Caspi et al., 2003; Huizink et al., 2004; Vazquez 
et al., 2002). 
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How does this modeling approach fit into the 
larger context of theoretical neuroscience? Neuro-
scientists have been using computational models to 
study aspects of brain function since the mid twen-
tieth century. Broadly, the areas of investigation can 
be lumped into two categories: single cells and net-
works (for an excellent overview of the field see the 
Nature Neuroscience Supplement Volume 3, Novem-
ber 2000). Decades of progress in computational neu-
roscience has resulted in exquisitely sophisticated 
biophysical models of neural firing (bottom–up) and 
network models of cognition (top–down). However, 
little emphasis has been placed on understanding the 
role of genetic variation in producing differences in 
the functioning of neural systems. The present model 
lies somewhere in between models of single neu-
rons and neural networks and utilizes a dynamic 
systems approach that has a long history in its own 
right and has been used to study the workings of the 
brain (von Bertalanffy, 1968; Wiener, 1961). The hope 
is that by using computational techniques we can ar-
rive at a better understanding of how heredity influ-
ences behavior. 
How important is it to understand epistatic in-
teraction in the 5-HT system? If epistasis is a funda-
mental feature of 5-HT functioning, then the genetic 
architectures for the myriad psychiatric disorders as-
sociated with 5-HT dysfunction must include gene–
gene interactions. Traditional approaches to identify 
genes underlying single gene disorders may not be 
suitable to identify genes in the presence of epistasis, 
which may explain some of the difficulty in identi-
fying genes for psychiatric disorders (Williams et al., 
2004). If epistasis is ubiquitous in common human 
diseases (Moore, 2003), new approaches will be re-
quired to study their etiology. 
Conclusion
This simulation of 5-HT regulation captures many im-
portant aspects of 5-HT function including epistasis. 
Epistatic interaction among presynaptic system com-
ponents appears to be an important feature of the 5-
HT system’s regulation of 5-HT levels, and therefore 
should be considered in studies that seek to under-
stand the influence of 5-HT system genetics on behav-
ior. The use of simulations should enable hypothesis 
generation and help to crystallize our understanding 
of an important neurotransmitter system. 
Appendix 1
Berkeley–Madonna 8.0.1 Code for Epistasis Model
INTEGRATION METHOD = EULER’S 
STARTTIME = 0 
STOPTIME = 50,000 
DT = 0.01 
{Reservoirs}
   d/dt (EXSER) = + ser_in  – ser_out 
INIT EXSER = 50 
   d/dt (SERFIRE) = + serFireRate 
INIT SERFIRE = 0 
   d/dt (IThreshold) = + threshAdjust 
INIT IThreshold = 50 
Flows 
ser_in = IF EXSER > IThreshold THEN 0 ELSE R 
ser_out = (REUPTAKE_RATE*EXSER) + 
(DIFFUSION*EXSER) 
serFireRate = IF ser_in > 0 THEN 1 ELSE 0 
threshAdjust = IF serFireRate = 0 THEN AU ELSE AD 
{Functions} 
AU = 5 
R = IF HT1B= 1 THEN (B/(EXSER+1))*100 ELSE (2*B) 
B = 50 
REUPTAKE_RATE = 0.90 
DIFFUSION = 0.1 
HT1B = 1 
AD = –5  
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